MSJ789884_data_supplement – Supplemental material for Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study
- Publication date
- Publisher
Abstract
<p>Supplemental material, MSJ789884_data_supplement for Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study by Jeffrey A Cohen, Giancarlo Comi, Douglas L Arnold, Amit Bar-Or, Krzysztof W Selmaj, Lawrence Steinman, Eva K Havrdová, Bruce AC Cree, Xavier Montalbán, Hans-Peter Hartung, Vivian Huang, Paul Frohna, Brett E Skolnick and Ludwig Kappos in Multiple Sclerosis Journal</p
